Angiodynamics (ANGO) Net Cash Flow Growth (1y) (2011 - 2026)
Angiodynamics (ANGO) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -9.88% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 19.23% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -593.75% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -179.69% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 134.67% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -196.55% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -213.73% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 102.38% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 126.33% |
| 10 | Angiodynamics | 655.49 Mn | 601.62 Mn | 46.77 Mn | 54.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 54.29% |
| Feb 28, 2026 | 56.57% |
| Nov 30, 2025 | 582.49% |
| Aug 31, 2025 | 18.17% |
| May 31, 2025 | 546.17% |
| Feb 28, 2025 | -152.36% |
| Nov 30, 2024 | -119.58% |
| Aug 31, 2024 | -263.41% |
| May 31, 2024 | -116.19% |
| Feb 29, 2024 | 10,549.70% |
| Nov 30, 2023 | -38.88% |
| Aug 31, 2023 | 428.34% |
| May 31, 2023 | 181.98% |
| Feb 28, 2023 | 101.58% |
| Nov 30, 2022 | 628.57% |
| Aug 31, 2022 | 68.57% |
| May 31, 2022 | 180.06% |
| Feb 28, 2022 | -194.88% |
| Nov 30, 2021 | -109.59% |
| Aug 31, 2021 | -85.71% |